Research Shows Demand for Cannabis Products Increases

According to Hexa Research, the U.S. medical cannabis market is projected to reach $19.48 billion by 2024.  The expected growth is driven by the expanding acceptance of medical advantages associated with cannabis, particularly for patients dealing with cancer, diabetes and chronic pain. Symptoms and conditions that may be treated by cannabis include, cancer, HIV, AIDS, Alzheimer’s disease, and multiple sclerosis. Chronic pain accounted for 46 percent of the U.S. cannabis medical market share in 2016. According to the research, the solid cannabis edibles segment in 2016, within the U.S. market generated $2.47 billion in revenue and is expected to continue to dominate the cannabis industry to 2024. Global Payout, Inc. (OTC: GOHE), SinglePoint, Inc. (OTC: SING), Mountain High Acquisitions Corp. (OTC: MYHI), American Cannabis Company, Inc. (OTC: AMMJ), Surna Inc. (OTC: SRNA)

California’s new recreational cannabis laws went into effect on January 1st, 2018. A report published by New Frontier

... read more at: